卓悅(00653.HK)澄清「Bonjour Beauty Limited (卓悅美容有限公司)」非集團附屬公司
卓悅控股(00653.HK)董事會注意到,近日有若干媒體報導有關一間名為「Bonjour Beauty Limited (卓悅美容有限公司)」之公司之訴訟程序。卓悅特此通知公司股東和潛在的投資者,Bonjour Beauty Limited (卓悅美容有限公司)並非集團之附屬公司,且該公司之任何訴訟程序與集團無關。
卓悅保留對任何未經證實的信息或聲明採取法律行動的權利。公司股東、公司的潛在投資者和公眾當收到未經核實、不準確或誤導的信息時,應格外謹慎處理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.